Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AVEO

AVEO Pharmaceuticals (AVEO)

Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVEO
DateTimeSourceHeadlineSymbolCompany
03/12/202112:58PMTipRanksWith FDA Approval in Place, AVEO Stock Could Be Worth $27, Says AnalystNASDAQ:AVEOAVEO Pharmaceuticals Inc
03/12/20217:55AMDow Jones NewsAVEO to Study Fotivda With Bristol's Opdivo in Kidney CancerNASDAQ:AVEOAVEO Pharmaceuticals Inc
03/10/20214:42PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
03/02/20217:00AMBusiness WireAVEO Oncology to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:AVEOAVEO Pharmaceuticals Inc
02/18/20217:00AMBusiness WireAVEO Oncology Announces Participation at the 2021 SVB Leerink Global Healthcare ConferenceNASDAQ:AVEOAVEO Pharmaceuticals Inc
02/16/20213:07PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
02/12/202112:40PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
02/11/20217:00AMBusiness WireAVEO Oncology Announces Presentation of Key Subgroup & Quality of Life Analyses from the Phase 3 TIVO-3 Study of Tivozanib in...NASDAQ:AVEOAVEO Pharmaceuticals Inc
02/08/20214:13PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
02/02/20213:15PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AVEOAVEO Pharmaceuticals Inc
01/29/20214:27PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
01/20/20217:00AMBusiness WireAVEO Oncology Announces Commitment for an Incremental $10 Million Loan in Addition to Current Tranched, $35 Million Debt Faci...NASDAQ:AVEOAVEO Pharmaceuticals Inc
01/15/20218:00AMBusiness WireAVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib (FOTIVDA®) in Combination with IMFINZI...NASDAQ:AVEOAVEO Pharmaceuticals Inc
01/12/20215:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
01/07/20217:00AMBusiness WireAVEO Oncology Highlights Recent Progress and 2021 OutlookNASDAQ:AVEOAVEO Pharmaceuticals Inc
01/06/20217:00AMBusiness WireAVEO Oncology Announces Participation at Two Upcoming Investor ConferencesNASDAQ:AVEOAVEO Pharmaceuticals Inc
01/05/20217:00AMBusiness WireAVEO Oncology Announces Webcast of Presentation at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:AVEOAVEO Pharmaceuticals Inc
11/20/20206:05AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AVEOAVEO Pharmaceuticals Inc
11/19/20206:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVEOAVEO Pharmaceuticals Inc
11/10/20207:00AMBusiness WireAVEO Oncology to Present at the Stifel 2020 Virtual Healthcare ConferenceNASDAQ:AVEOAVEO Pharmaceuticals Inc
11/09/20205:07PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AVEOAVEO Pharmaceuticals Inc
11/09/20204:05PMBusiness WireAVEO Oncology Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:AVEOAVEO Pharmaceuticals Inc
11/05/20207:00AMBusiness WireAVEO Oncology & EUSA Pharma Announce Annals of Oncology Publication of Data from Phase 1b/2 TiNivo Study in Renal Cell Carcin...NASDAQ:AVEOAVEO Pharmaceuticals Inc
10/19/20207:00AMBusiness WireAVEO Oncology Announces Appointment of David W. Crist as Vice President of SalesNASDAQ:AVEOAVEO Pharmaceuticals Inc
09/28/20208:30AMInvestorsHub NewsWireImminent Reverse Merger Brings Windfall To Rafarma Pharmaceuticals Shareholders - RAFA Shares Could Surprise BigNASDAQ:AVEOAVEO Pharmaceuticals Inc
09/15/20204:05PMBusiness WireAVEO Oncology Announces European Urology Publication of Final Overall Survival Data from Phase 3 TIVO-3 Study of Tivozanib in...NASDAQ:AVEOAVEO Pharmaceuticals Inc
09/08/20207:00AMBusiness WireAVEO Oncology Regains Full Global Rights to FiclatuzumabNASDAQ:AVEOAVEO Pharmaceuticals Inc
09/03/20207:00AMBusiness WireAVEO Oncology Announces Participation at Two Upcoming Investor ConferencesNASDAQ:AVEOAVEO Pharmaceuticals Inc
08/10/20204:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
08/10/20204:05PMBusiness WireAVEO Oncology Announces Restructuring of Existing Term Loan with Closing of New Tranched, $35 Million Debt FacilityNASDAQ:AVEOAVEO Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AVEO